tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie’s Phase 3 Pediatric Constipation Study Completes, Potential Market Impact Looms
Company AnnouncementsAbbVie’s Phase 3 Pediatric Constipation Study Completes, Potential Market Impact Looms
1d ago
ABBV
AbbVie’s Psoriasis Study Completes: Key Insights for Investors
PremiumCompany Announcements
AbbVie’s Psoriasis Study Completes: Key Insights for Investors
1d ago
ABBV
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
PremiumThe Fly
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
1d ago
ABBV
AVTX
Oruka Therapeutics Stock (ORKA) Soars on New Psoriasis Drug That Could Challenge AbbVie (ABBV)
PremiumMarket News
Oruka Therapeutics Stock (ORKA) Soars on New Psoriasis Drug That Could Challenge AbbVie (ABBV)
1d ago
ABBV
OKRA
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
PremiumThe Fly
Netflix upgraded, Five Below initiated: Wall Street’s top analyst calls
1d ago
Z
KR
AbbVie’s Strategic Positioning and Growth Prospects Highlight Compelling Investment Opportunity
PremiumRatingsAbbVie’s Strategic Positioning and Growth Prospects Highlight Compelling Investment Opportunity
2d ago
ABBV
AbbVie upgraded to Buy from Hold at Berenberg
Premium
The Fly
AbbVie upgraded to Buy from Hold at Berenberg
2d ago
ABBV
AbbVie price target raised to $235 from $200 at JPMorgan
Premium
The Fly
AbbVie price target raised to $235 from $200 at JPMorgan
2d ago
ABBV
AbbVie price target raised to $245 from $215 at Cantor Fitzgerald
PremiumThe Fly
AbbVie price target raised to $245 from $215 at Cantor Fitzgerald
3d ago
ABBV
AbbVie price target raised to $240 from $215 at BMO Capital
PremiumThe Fly
AbbVie price target raised to $240 from $215 at BMO Capital
7d ago
ABBV
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories!
7d ago
KR
AMD
AbbVie’s ABBV-1088 Study: A Closer Look at Recent Developments
PremiumCompany Announcements
AbbVie’s ABBV-1088 Study: A Closer Look at Recent Developments
7d ago
ABBV
AbbVie’s Rinvoq Franchise Secures Extended Exclusivity, Boosting Long-Term Prospects and Justifying Buy Rating
PremiumRatingsAbbVie’s Rinvoq Franchise Secures Extended Exclusivity, Boosting Long-Term Prospects and Justifying Buy Rating
7d ago
ABBV
‘Really Long Runway’: AbbVie Stock (ABBV) Jumps afer Settlement on Anti-Inflammatory Drug
Premium
Market News
‘Really Long Runway’: AbbVie Stock (ABBV) Jumps afer Settlement on Anti-Inflammatory Drug
7d ago
WFC
ABBV
Wells sees AbbVie Rinvoq settlement being worth $11-$24 per share
Premium
The Fly
Wells sees AbbVie Rinvoq settlement being worth $11-$24 per share
7d ago
ABBV
AbbVie settles litigation with all generic manufacturers of Rinvoq
PremiumThe Fly
AbbVie settles litigation with all generic manufacturers of Rinvoq
7d ago
ABBV
AbbVie jumps 4% to $220.77 after settling with Rinvoq generic makers
PremiumThe Fly
AbbVie jumps 4% to $220.77 after settling with Rinvoq generic makers
7d ago
ABBV
AbbVie Settles to Delay RINVOQ Generics Until 2037
PremiumCompany Announcements
AbbVie Settles to Delay RINVOQ Generics Until 2037
7d ago
8K
ABBV
AstraZeneca and AbbVie: New Phase II Study Targets Relapsed CLL/SLL
PremiumCompany Announcements
AstraZeneca and AbbVie: New Phase II Study Targets Relapsed CLL/SLL
11d ago
AZN
ABBV
AbbVie’s ABBV-525 Study: A Potential Game-Changer in B-Cell Malignancies
PremiumCompany AnnouncementsAbbVie’s ABBV-525 Study: A Potential Game-Changer in B-Cell Malignancies
11d ago
ABBV
AbbVie’s Promising Phase 2 Study on ABBV-932 for Anxiety Disorder
Premium
Company Announcements
AbbVie’s Promising Phase 2 Study on ABBV-932 for Anxiety Disorder
11d ago
ABBV
AbbVie’s Promising Study on ABBV-706 for Small Cell Lung Cancer
Premium
Company Announcements
AbbVie’s Promising Study on ABBV-706 for Small Cell Lung Cancer
11d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >